-
24.02.2025
Online information session in Portuguese on February 27, 2025 at 11:00 AM GMT; Participation is free, but it is necessary to register for the Webinar here
The Global Health EDCTP3 Partnership launched the 2025 Call for Combating Infectious Diseases and Supporting Development Activities for Funding Collaborative Research and Innovation Capacity Research Projects in Africa.
-
The Global Health European & Developing Countries Clinical Trials Joint Undertaking (GH EDCTP3 JU) is a partnership between the European Union and African countries, established for the period 2021 to 2031. This initiative aims to develop innovative or improved health technologies to identify, treat and prevent neglected and poverty-related infectious diseases, including those (re)emerging and affecting sub-Saharan Africa.
Additionally, the GH EDCTP3 JU funds research capacity building activities in Africa, supporting researchers' careers and strengthening national health research systems. The aim is to improve the capacity of sub-Saharan African countries to identify and respond to health challenges related to infectious diseases.
-
The calls will support a range of Research and Innovation Actions (RIA) aimed at developing novel vaccines and therapeutics for tuberculosis, malaria, and neglected tropical diseases:
- Vaccines for reducing the disease burden of tuberculosis in sub-Saharan Africa
- Malaria therapeutics and clinical development of new antimalarial candidates
- Accelerating the development of prophylactic vaccines against neglected tropical diseases.
Additionally, Coordination and Support Actions (CSA) will strengthen the enabling environment for conducting clinical research in Africa, through fellowships in public health with an emphasis on biostatistics, epidemiology, and modelling, as well as through regional networks of excellence for preparedness and response to outbreaks:
- Strategic training hubs for fellowships in public health
- Strengthening the regional networks of excellence and epidemic preparedness consortia.
The rapidly growing climate and health challenge will be addressed in a dedicated topic focused on tackling diarrheal diseases. Furthermore, there will be an effort to foster novel and emerging transformative innovations in global health, aiming to serve underserved populations and make interventions more affordable and accessible. Both topics are Research and Innovation Actions (RIA):
- Tackling diarrheal diseases in the context of climate and health transformative innovations
- Transformative innovations in global health.
For more details on the topics see the Work Program 2025 in the 'Call Document section'.
-
All proposals must be submitted electronically through the Funders & Tenders Portal electronic submission system. Detailed instructions in the annexes E (documents) and Annex F (procedures) of the 2025 Work Program available at the Call Documents section.
-
The list of eligible countries and other conditions of admissibility, eligibility and Award Criteria are described respectively in the annexes A, B and D of the 2025 Work Program available at the Call Documents section.
-
-